These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9853191)

  • 41. Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
    Liang CS; Frantz RP; Suematsu M; Sakamoto S; Sullebarger JT; Fan TM; Guthinger L
    Circulation; 1991 Jul; 84(1):254-66. PubMed ID: 1676348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimulation of beta-adrenergic receptors inhibits the release of tumor necrosis factor-alpha from the isolated rat heart.
    Newman WH; Castresana MR; Webb JG; Wang Z; Warejcka DJ
    Crit Care Med; 2000 Nov; 28(11):3593-8. PubMed ID: 11098959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The sympathetic nervous system in chronic heart failure.
    Joseph J; Gilbert EM
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):9-16. PubMed ID: 9715818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New concepts in post-infarction ventricular remodeling.
    Udelson JE; Patten RD; Konstam MA
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
    Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
    Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies.
    Takano H; Hasegawa H; Nagai T; Komuro I
    Intern Med; 2003 Jun; 42(6):465-9. PubMed ID: 12857042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study.
    Newton GE; Azevedo ER; Parker JD
    Circulation; 1999 May; 99(18):2402-7. PubMed ID: 10318661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myocardial dysfunction: hibernation and remodelling.
    Köszegi Z; Balogh E
    Lancet; 2003 Oct; 362(9393):1416-7; author reply 1417. PubMed ID: 14585649
    [No Abstract]   [Full Text] [Related]  

  • 50. Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.
    Ruffolo RR; Kopia GA
    Am J Med; 1986 Feb; 80(2B):67-72. PubMed ID: 2868661
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR
    J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of β-adrenergic system remodeling in human heart failure: A mechanistic investigation.
    Mora MT; Gong JQX; Sobie EA; Trenor B
    J Mol Cell Cardiol; 2021 Apr; 153():14-25. PubMed ID: 33326834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Adrenergic Blocker, Carvedilol, Abolishes Ameliorating Actions of Adipose-Derived Stem Cell Sheets on Cardiac Dysfunction and Remodeling After Myocardial Infarction.
    Adachi M; Watanabe M; Kurata Y; Inoue Y; Notsu T; Yamamoto K; Horie H; Tanno S; Morita M; Miake J; Hamada T; Kuwabara M; Nakasone N; Ninomiya H; Tsuneto M; Shirayoshi Y; Yoshida A; Nishimura M; Yamamoto K; Hisatome I
    Circ J; 2019 Oct; 83(11):2282-2291. PubMed ID: 31527337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic effects on cardiac remodeling.
    Sharpe N
    Curr Heart Fail Rep; 2004; 1(1):9-13. PubMed ID: 16036019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left ventricular remodelling during treatment with beta-blockers.
    Ertl G; Hu K
    J Cardiovasc Risk; 1999 Jun; 6(3):145-50. PubMed ID: 10463140
    [No Abstract]   [Full Text] [Related]  

  • 56. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure.
    Song YH; Li BS; Chen XM; Cai H
    Int J Mol Med; 2008 Jan; 21(1):117-24. PubMed ID: 18097624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure.
    Reis Filho JR; Cardoso JN; Cardoso CM; Pereira-Barretto AC
    Arq Bras Cardiol; 2015 Jun; 104(6):502-6. PubMed ID: 26131706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catecholamines and their blockade in congestive heart failure.
    White CM
    Am J Health Syst Pharm; 1998 Apr; 55(7):676-82. PubMed ID: 9558423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.